Australia markets closed

Kiromic BioPharma, Inc. (KRBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3800+0.0085 (+2.29%)
At close: 03:57PM EDT
0.3852 +0.01 (+1.37%)
After hours: 06:57PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.3715
Open0.3651
Bid0.3300 x 1000
Ask0.0000 x 900
Day's range0.3651 - 0.3940
52-week range0.2300 - 4.6000
Volume100,801
Avg. volume1,347,369
Market cap6.019M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-2.1820
Earnings date11 Aug 2022 - 15 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Kiromic BioPharma Appoints Leonardo Mirandola, Ph.D. as Chief Scientific Officer

    HOUSTON, July 12, 2022--Kiromic BioPharma, Inc. (NASDAQ: KRBP) ("Kiromic" or the "Company"), a clinical-stage fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence and data mining platform to develop cell and gene therapies with a focus on immuno-oncology, announces the appointment of Leonardo Mirandola, Ph.D., as Chief Scientific Officer, effective immediately. Dr. Mirandola has served as the Company’s Vice President of Research & Development and Clinic

  • Business Wire

    Kiromic BioPharma Achieves Milestone with Timely Completion of Expanded cGMP Manufacturing Facility to Support Cell Therapy Oncology Pipeline

    HOUSTON, July 07, 2022--Kiromic BioPharma, Inc. (NASDAQ: KRBP) ("Kiromic" or the "Company"), a clinical-stage fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence and data mining platform to develop cell and gene therapies with a focus on immuno-oncology, announces the timely completion of construction on its expanded current good manufacturing practice (cGMP) manufacturing facility in Houston. This significant milestone was accomplished within the time

  • GlobeNewswire

    UPDATE -- Diamond Equity Research to Host Emerging Growth Invitational Virtual Investor Conference on June 23, 2022

    Presenting Companies to Host 25 Minute Presentations Followed by Question-and-Answer Session; Conference Open to all Retail and Institutional InvestorsNEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will host its quarterly Emerging Growth Invitational investor conference on June 23, 2022. The conference, which is open to all retail and institutional investors, will consist of a series of twenty-five-minu